Explore every episode of the podcast JAMA Neurology Author Interviews
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Localized Nicardipine Release Implants for Prevention of Vasospasm | 19 Aug 2024 | 00:15:20 | |
Interview with Peter Vajkoczy, MD, author of Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. | |||
| Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events | 08 Jul 2024 | 00:19:32 | |
Interview with Allison W. Willis, MD, MS, author of Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events. Hosted by Cynthia E. Armand, MD. | |||
| Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease | 30 Oct 2023 | 00:17:27 | |
Interview with Richard A. Bernstein, MD, PhD, author of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. | |||
| Sleep Quality and Preclinical Alzheimer Disease | 11 Mar 2013 | 00:06:56 | |
Interview with David M. Holtzman, MD and Yo-El S. Ju, MD, authors of Sleep Quality and Preclinical Alzheimer Disease | |||
| Hospital-Onset Seizures: An Inpatient Study | 14 Jan 2013 | 00:05:27 | |
Interview with Madeline C. Fields, MD, author of Hospital-Onset Seizures: An Inpatient Study | |||
| Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease and Apolipoprotein E, Neurodegeneration, and Alzheimer Diseas | 03 Dec 2012 | 00:07:41 | |
Interview with Eric M. Reiman, MD and Hillary D. Protas, PhD, authors of Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease, and William Jagust, MD, author of Apolipoprotein E, Neurodegeneration, and Alzheimer Disease | |||
| Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis and Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis | 03 Oct 2012 | 00:13:14 | |
Interview with Ari J Green, MD, author of Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis, and Shiv Saidha, MBBCh, MRCPI, author of Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis | |||
| Growth Hormone-Releasing Hormone Improves Cognitive Function in Mild Cognitive Impairment and Healthy Aging: Results of a Controlled Trial | 13 Aug 2012 | 00:14:21 | |
Interview with Laura D. Baker, PhD, author of Growth Hormone-Releasing Hormone Improves Cognitive Function in Mild Cognitive Impairment and Healthy Aging: Results of a Controlled Trial | |||
| Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia | 18 Jun 2012 | 00:10:53 | |
Interview with Kristine Yaffe, MD, author of Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia | |||
| Frontotemporal Dementia in a Brazilian Kindred With the C9orf72 Mutation | 14 May 2012 | 00:11:22 | |
Interview with Leonel T. Takada, MD, author of Frontotemporal Dementia in a Brazilian Kindred With the C9orf72 Mutation | |||
| Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy and Autoantibodies in the Patient With Drug-Resistant Epilepsy: Are We Missing a Treatable Etiology? | 26 Mar 2012 | 00:12:40 | |
Interview with Sean J. Pittock, MD, author of Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy and Gregory K. Bergey, MD author of Autoantibodies in the Patient With Drug-Resistant Epilepsy: Are We Missing a Treatable Etiology? | |||
| Pattern Classification of Volitional Functional Magnetic Resonance Imaging Responses in Patients With Severe Brain Injury and Wait, Wait...Don't Tell Me: Tuning In the Injured Brain | 13 Feb 2012 | 00:11:16 | |
Interview with Nicholas D. Schiff, MD, author of Pattern Classification of Volitional Functional Magnetic Resonance Imaging Responses in Patients With Severe Brain Injury and Joseph J. Fins, MD, author of Wait, Wait...Don't Tell Me: Tuning In the Injured Brain | |||
| Longitudinal Change of Biomarkers in Cognitive Decline | 10 Oct 2011 | 00:06:33 | |
Interview with William J. Jagust, MD, author of Longitudinal Change of Biomarkers in Cognitive Decline | |||
| Neuropathologic and Clinical Findings in Athletes With Repetitive Head Impacts | 28 Aug 2023 | 00:16:39 | |
Interview with Ann C. McKee, MD, author of Neuropathologic and Clinical Findings in Young Contact Sport Athletes Exposed to Repetitive Head Impacts. Hosted by Cynthia E. Armand, MD. | |||
| Dementia Risk and Disadvantaged Neighborhoods | 19 Jul 2023 | 00:17:08 | |
Interview with Kristine Yaffe, MD, author of Dementia Risk and Disadvantaged Neighborhoods. Hosted by Cynthia E. Armand, MD. | |||
| Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence | 20 Jun 2023 | 00:13:47 | |
Interview with Sándor Beniczky, MD, PhD, author of Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence. Hosted by Cynthia Armand, MD. | |||
| Risk of Parkinson Disease Among Camp Lejeune Veterans | 15 May 2023 | 00:21:24 | |
Interview with Samuel M. Goldman, MD, MPH, author of Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. Hosted by Cynthia E. Armand, MD. | |||
| Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders | 17 Apr 2023 | 00:17:21 | |
Interview with Julie Werenberg Dreier, PhD, author of Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. Hosted by Cynthia E. Armand, MD. | |||
| Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors | 27 Mar 2023 | 00:19:36 | |
Interview with Xin You Tai, MD, author of Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors. Hosted by Cynthia E. Armand, MD. | |||
| Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke | 23 Feb 2023 | 00:17:09 | |
Interview with Pierce Boyne, PT, DPT, PhD, NCS, author of Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. | |||
| Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known Well | 27 Dec 2022 | 00:16:34 | |
Interview with Amrou Sarraj, MD, author of Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study. Hosted by Cynthia E. Armand, MD. | |||
| Autoimmune Encephalitis Misdiagnosis in Adults | 28 Nov 2022 | 00:17:30 | |
Interview with Eoin P. Flanagan, MD, author of Autoimmune Encephalitis Misdiagnosis in Adults. Hosted by Cynthia E. Armand, MD. | |||
| Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation | 28 May 2024 | 00:18:13 | |
Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. | |||
| Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease | 31 Oct 2022 | 00:19:29 | |
Interview with Camille Carroll, MD, PhD, author of Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. | |||
| Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy | 26 Sep 2022 | 00:16:56 | |
Interview with Håkon Magne Vegrim, MD, author of Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy.Hosted by Cynthia E. Armand, MD. | |||
| Association of Neurocritical Care With Outcomes for Adults With Brain Injury | 29 Aug 2022 | 00:20:27 | |
Interview with Andrew A. Udy, BHB, MBChB, PhD, author of Association of Neurocritical Care Services With Mortality and Functional Outcomes for Adults With Brain Injury: A Systematic Review and Meta-analysis. Hosted by Cynthia E. Armand, MD. | |||
| Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo | 18 Jul 2022 | 00:17:44 | |
Interview with Benton R. Hunter, MD, author of Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo: A Systematic Review and Meta-analysis. Hosted by Cynthia E. Armand, MD. | |||
| A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief | 05 Jul 2022 | 00:22:07 | |
In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. | |||
| Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the US | 27 Jun 2022 | 00:23:32 | |
Interview with Renee Y. Hsia, MD, MSc, author of Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the United States. Hosted by Cynthia E. Armand, MD. | |||
| Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability | 31 May 2022 | 00:18:43 | |
Interview with Marte-Helene Bjørk, MD, PhD, author of Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. Hosted by Cynthia E. Armand, MD. | |||
| Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19 | 11 Apr 2022 | 00:16:55 | |
Interview with Cheng-Ying Ho, MD, PhD, author of Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19. Hosted by Cynthia E. Armand, MD. | |||
| Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury | 21 Feb 2022 | 00:18:21 | |
Interview with Joshua Laing, MBBS, author of Risk Factors and Prognosis of Early Posttraumatic Seizures in Moderate-Severe Traumatic Brain Injury. Hosted by Cynthia E. Armand, MD.
Notes: EPS: Extrapyramidal symptoms GCS: Glasgow Coma Scale | |||
| Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy | 18 Jan 2022 | 00:17:01 | |
Interview with Sara K. Rostanski, MD, author of Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial Hosted by Cynthia E. Armand, MD. | |||
| Association of New-Onset Seizures With SARS-CoV-2 Vaccines | 29 Apr 2024 | 00:16:43 | |
Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD. | |||
| Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura | 20 Dec 2021 | 00:20:25 | |
Interview with Messoud Ashina, MD, DrMSc, author of Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials Hosted by Cynthia E. Armand, MD. | |||
| Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy Bodies | 22 Nov 2021 | 00:18:47 | |
Interview with Dag Aarsland, MD, and Maria C. Gonzalez, MD, authors of Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies. Hosted by Cynthia E. Armand, MD. | |||
| Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up | 18 Oct 2021 | 00:24:32 | |
| Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis | 20 Sep 2021 | 00:24:28 | |
Interview with Ming Lim, MD, PhD, and Sarosh R. Irani, MD, PhD, authors of Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis | |||
| Risk of Rupture After Intracranial Aneurysm Growth | 30 Aug 2021 | 00:24:06 | |
Interview with Laura Tessa van der Kamp, MD, and Mervyn D Vergouwen, MD, PhD, authors of Risk of Rupture After Intracranial Aneurysm Growth | |||
| Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage | 26 Jul 2021 | 00:22:16 | |
Interview with Lidia Moura, MD, MPH, author of Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage | |||
| Tau PET as a Prognostic Marker | 28 Jun 2021 | 00:15:24 | |
Interview with Rik Ossenkoppele, PhD, author of Accuracy of Tau PET as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease—A Head-to-Head Comparison Against Amyloid PET and MRI. | |||
| Association of Nitrogen Dioxide and Other Air Pollution Exposures With the Risk of Parkinson Disease | 17 May 2021 | 00:21:22 | |
Interview with Sun Ju Chung, MD, PhD, author of Association of NO2 and Other Air Pollution Exposures With the Risk of Parkinson Disease | |||
| Effect of High-Frequency (10 kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy | 05 Apr 2021 | 00:23:42 | |
Interview with Erika Petersen, MD, author of Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial | |||
| Reperfusion Treatment and Stroke Outcomes in Hospitals with Telestroke Capacity | 01 Mar 2021 | 00:21:22 | |
Interview with Ateev Mehrotra, MD, author of Reperfusion Treatment and Stroke Outcomes in Hospitals With Telestroke Capacity | |||
| High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS | 25 Mar 2024 | 00:14:08 | |
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. | |||
| Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era | 25 Jan 2021 | 00:17:30 | |
Interview with Deborah E. Barnes, PhD, MPH, author of Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era | |||
| Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor | 21 Dec 2020 | 00:22:16 | |
Interview with Roopa Rajan, MD, DM, author of Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial | |||
| Prehospital Prediction of Large Anterior Vessel Occlusion | 30 Nov 2020 | 00:23:10 | |
Interview with T. Truc My Nguyen, MD, and Nyika D. Kruyt, MD, PhD, authors of Comparison of Prehospital Scales for Predicting Large Anterior Vessel Occlusion in the Ambulance Setting | |||
| ED and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders | 26 Oct 2020 | 00:18:12 | |
Interview with Christopher D. Stephen, MB, author of Assessment of Emergency Department and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders | |||
| Optic Neuritis Incidence and Prevalence and Association With Systemic and Neurologic Disease | 05 Oct 2020 | 00:28:38 | |
Interview with Tasanee Braithwaite, author of Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease | |||